JPWO2023287861A5 - - Google Patents
Info
- Publication number
- JPWO2023287861A5 JPWO2023287861A5 JP2024501751A JP2024501751A JPWO2023287861A5 JP WO2023287861 A5 JPWO2023287861 A5 JP WO2023287861A5 JP 2024501751 A JP2024501751 A JP 2024501751A JP 2024501751 A JP2024501751 A JP 2024501751A JP WO2023287861 A5 JPWO2023287861 A5 JP WO2023287861A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- peg
- itr
- alkyl
- independently
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163221290P | 2021-07-13 | 2021-07-13 | |
| US63/221,290 | 2021-07-13 | ||
| PCT/US2022/036930 WO2023287861A2 (en) | 2021-07-13 | 2022-07-13 | Single chain variable fragment (scfv) modified lipid nanoparticle compositions and uses thereof |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2024529343A JP2024529343A (ja) | 2024-08-06 |
| JP2024529343A5 JP2024529343A5 (https=) | 2025-07-16 |
| JPWO2023287861A5 true JPWO2023287861A5 (https=) | 2025-07-16 |
Family
ID=84920581
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024501751A Pending JP2024529343A (ja) | 2021-07-13 | 2022-07-13 | 一本鎖可変断片（ｓｃＦｖ）修飾脂質ナノ粒子組成物及びその使用 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20240382432A1 (https=) |
| EP (1) | EP4370135A4 (https=) |
| JP (1) | JP2024529343A (https=) |
| KR (1) | KR20240035821A (https=) |
| CN (1) | CN118159278A (https=) |
| AU (1) | AU2022311904A1 (https=) |
| CA (1) | CA3225694A1 (https=) |
| IL (1) | IL309767A (https=) |
| MX (1) | MX2024000670A (https=) |
| WO (1) | WO2023287861A2 (https=) |
| ZA (1) | ZA202400158B (https=) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL309767A (en) * | 2021-07-13 | 2024-02-01 | Generation Bio Co | Single chain variable fragment (scfv) modified lipid nanoparticle compositions and uses thereof |
| US20240226133A1 (en) * | 2023-01-09 | 2024-07-11 | Claudia Chimisso Dos Santos | Microrna-based particle for the treatment of dysregulated immune response |
| US12311033B2 (en) | 2023-05-31 | 2025-05-27 | Capstan Therapeutics, Inc. | Lipid nanoparticle formulations and compositions |
| WO2025090417A1 (en) * | 2023-10-24 | 2025-05-01 | Generation Bio Co. | Bispecific stealth lipid nanoparticle compositions for cell targeting |
| WO2025090138A1 (en) * | 2023-10-24 | 2025-05-01 | Generation Bio Co. | Stealth lipid nanoparticle compositions for cell targeting |
| WO2025150516A1 (ja) * | 2024-01-12 | 2025-07-17 | 日油株式会社 | 核酸内封脂質ナノ粒子を含む凍結組成物 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2017027325A1 (en) * | 2015-08-07 | 2017-02-16 | Imaginab, Inc. | Antigen binding constructs to target molecules |
| WO2018200951A1 (en) * | 2017-04-28 | 2018-11-01 | Tran David T | Multi-targeted multi-valent ligand-drug particles for the treatment and prevention of diseases and conditions |
| US20200093936A1 (en) * | 2018-09-21 | 2020-03-26 | The Trustees Of The University Of Pennsylvania | Therapeutic Targeting of Lipid Nanoparticles |
| AU2020397956A1 (en) * | 2019-12-04 | 2022-07-07 | Orna Therapeutics, Inc. | Circular RNA compositions and methods |
| IL309767A (en) * | 2021-07-13 | 2024-02-01 | Generation Bio Co | Single chain variable fragment (scfv) modified lipid nanoparticle compositions and uses thereof |
-
2022
- 2022-07-13 IL IL309767A patent/IL309767A/en unknown
- 2022-07-13 CN CN202280055244.2A patent/CN118159278A/zh active Pending
- 2022-07-13 KR KR1020247004144A patent/KR20240035821A/ko active Pending
- 2022-07-13 WO PCT/US2022/036930 patent/WO2023287861A2/en not_active Ceased
- 2022-07-13 AU AU2022311904A patent/AU2022311904A1/en active Pending
- 2022-07-13 MX MX2024000670A patent/MX2024000670A/es unknown
- 2022-07-13 US US18/578,073 patent/US20240382432A1/en active Pending
- 2022-07-13 JP JP2024501751A patent/JP2024529343A/ja active Pending
- 2022-07-13 CA CA3225694A patent/CA3225694A1/en active Pending
- 2022-07-13 EP EP22842796.9A patent/EP4370135A4/en active Pending
-
2024
- 2024-01-03 ZA ZA2024/00158A patent/ZA202400158B/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Kulkarni et al. | The current landscape of nucleic acid therapeutics | |
| JP4796062B2 (ja) | 脂質封入干渉ｒｎａ | |
| CN101291653B (zh) | 脂质包封的干扰rna | |
| US20060051405A1 (en) | Compositions for the delivery of therapeutic agents and uses thereof | |
| JPWO2022016089A5 (https=) | ||
| CN101163796B (zh) | 阳离子脂质及应用方法 | |
| JP2008501729A (ja) | カチオン性脂質および使用方法 | |
| JP2024522692A (ja) | カチオン性脂質及びその組成物 | |
| US20240382432A1 (en) | Single chain variable fragment (scfv) modified lipid nanoparticle compositions and uses thereof | |
| JP2023527747A (ja) | 新規脂質及びそれらのナノ粒子組成物 | |
| Mohammad | Key considerations in formulation development for gene therapy products | |
| KR20250131271A (ko) | 신규한 폴리글리세롤-접합된 지질 및 이를 포함하는 지질 나노입자 조성물 | |
| JPWO2022261101A5 (https=) | ||
| WO2024119103A1 (en) | Lipid nanoparticles comprising nucleic acids and lipid-anchored polymers | |
| JPWO2023287861A5 (https=) | ||
| JPWO2022226008A5 (https=) | ||
| KR20250129819A (ko) | 핵산, 이온화 가능한 지질, 스테롤, 지질에 고정된 중합체, 및 헬퍼 지질을 포함하는 지질 나노입자 및 이의 용도 | |
| JPWO2022266032A5 (https=) | ||
| RU2023136316A (ru) | КОМПОЗИЦИИ МОДИФИЦИРОВАННЫХ ЛИПИДНЫХ НАНОЧАСТИЦ С ОДНОЦЕПОЧЕЧНЫМ ВАРИАБЕЛЬНЫМ ФРАГМЕНТОМ (scFv) И ИХ ПРИМЕНЕНИЯ | |
| US20260041785A1 (en) | Polyglycerol-conjugated lipids and lipid nanoparticle compositions comprising the same | |
| Bremner et al. | Antisense strategies and non-viral gene therapy for cancer | |
| Goodwin et al. | Lipids in DNA, RNA, and Peptide Delivery for In Vivo Therapeutic Applications | |
| KR20250158420A (ko) | 신규 이온화지질 및 이를 포함하는 지질나노입자 |